Background:
Preoperative biliary drainage (PBD) prior to liver resection for hilar and intrahepatic cholangiocarcinoma (CCA) is common. While PBD for those with distal obstructions has been studied extensively and is associated with increased infectious complications, the impact of PBD among patients undergoing hepatectomy for non-disseminated proximal CCA has yet to be clearly elucidated.
Methods:
Patients undergoing liver resection between 2014 and 2016 for non-disseminated hilar and intrahepatic CCA were analyzed using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. Associations between PBD (percutaneous or endoscopic) and 30-day outcomes were evaluated.
Results:
There were 905 liver resections performed, with 186 (20.6%) for hilar CCA and 719 (79.4%) for intrahepatic CCA. Of those, 251/897 (28.0%) patients underwent PBD. Independent preoperative predictors of PBD were hilar CCA, major hepatectomy, open surgery, lower BMI, and higher preoperative bilirubin. Adjusting for preoperative variables, extent of resection, and bilirubin, PBD was independently associated with increased wound infection (OR 2.93), organ space infection (OR 3.63), sepsis (OR 3.17), renal insufficiency (OR 4.25), transfusion (OR 2.40), bile leak (OR 3.23), invasive intervention (OR 2.72), liver failure (OR 3.20), readmission (OR 3.01), reoperation (OR 2.32), and mortality (OR 4.24, all p < 0.05).
Conclusions:
Among patients undergoing hepatectomy for proximal CCA, PBD is associated with increased postoperative complications. These data suggest that avoidance of routine preoperative biliary drainage may decrease short-term complications.
Citing Articles
Time to Surgery Does Not Affect the Survival Outcome in Patients with Perihilar Cholangiocarcinoma.
Tohmatsu Y, Ohgi K, Ashida R, Yamada M, Otsuka S, Kato Y
Ann Surg Oncol. 2024; 32(3):1808-1816.
PMID: 39633168
DOI: 10.1245/s10434-024-16628-4.
Total laparoscopic radical resection of hilar cholangiocarcinoma: preliminary experience of a single center.
Du Y, Wang J, Liu L, Ma H, Zhao W, Li Y
BMC Surg. 2024; 24(1):241.
PMID: 39182023
PMC: 11344452.
DOI: 10.1186/s12893-024-02533-w.
Persistent hyperbilirubinemia following preoperative biliary stenting in patients undergoing anatomic hepatectomy predicts serious complications.
Kirkland M, Verhoeff K, Jogiat U, Mocanu V, Shapiro A, Anderson B
Surg Endosc. 2024; 38(8):4287-4295.
PMID: 38872019
DOI: 10.1007/s00464-024-10968-8.
Dynamic three-dimensional liver volume assessment of liver regeneration in hilar cholangiocarcinoma patients undergoing hemi-hepatectomy.
Zhao H, Li B, Li X, Lv X, Guo T, Dai Z
Front Oncol. 2024; 14:1375648.
PMID: 38706591
PMC: 11067054.
DOI: 10.3389/fonc.2024.1375648.
Role of ablation therapy in conjunction with surgical resection for neuroendocrine tumors involving the liver.
Ostapenko A, Stroever S, Eyasu L, Kim M, Aploks K, Dong X
World J Gastrointest Surg. 2024; 16(3):768-776.
PMID: 38577070
PMC: 10989351.
DOI: 10.4240/wjgs.v16.i3.768.
Safety and feasibility of laparoscopic radical resection for bismuth types III and IV hilar cholangiocarcinoma: a single-center experience from China.
Wang J, Xia Y, Cao Y, Zeng X, Luo H, Cai X
Front Oncol. 2024; 13:1280513.
PMID: 38188306
PMC: 10766688.
DOI: 10.3389/fonc.2023.1280513.
Biliary drainage in malignant biliary obstruction: an umbrella review of randomized controlled trials.
Wang Y, Wen N, Xiong X, Li B, Lu J
Front Oncol. 2023; 13:1235490.
PMID: 37731638
PMC: 10508238.
DOI: 10.3389/fonc.2023.1235490.
Pre- and postoperative C-reactive protein as a risk factor of organ/space surgical site infection after hepatectomy.
Yasuda S, Hokuto D, Kamitani N, Matsuo Y, Doi S, Nakagawa K
Langenbecks Arch Surg. 2023; 408(1):13.
PMID: 36622470
DOI: 10.1007/s00423-023-02760-4.
Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022.
Joliat G, Kobayashi K, Hasegawa K, Thomson J, Padbury R, Scott M
World J Surg. 2022; 47(1):11-34.
PMID: 36310325
PMC: 9726826.
DOI: 10.1007/s00268-022-06732-5.
The Clinical Benefit of Percutaneous Transhepatic Biliary Drainage for Malignant Biliary Tract Obstruction.
Nikolic I, Radic J, Petres A, Djuric A, Protic M, Litavski J
Cancers (Basel). 2022; 14(19).
PMID: 36230596
PMC: 9563508.
DOI: 10.3390/cancers14194673.
Case report: Conversion therapy for advanced intrahepatic cholangiocarcinoma using PD-1 inhibitor plus S-1 and nab-paclitaxel.
Li X, Jiang Z, Wu Y, Gong W, Liao X, Li X
Front Oncol. 2022; 12:935817.
PMID: 35965578
PMC: 9366243.
DOI: 10.3389/fonc.2022.935817.
[Cholangiocarcinoma-Intrahepatic to hilar bile duct cancer].
Rademacher S, Denecke T, Berg T, Seehofer D
Chirurgie (Heidelb). 2022; 93(7):644-651.
PMID: 35771272
DOI: 10.1007/s00104-022-01660-5.
The Interplay Between Biliary Occlusion and Liver Regeneration: Repeated Regeneration Stimuli Restore Biliary Drainage by Promoting Hepatobiliary Remodeling in a Rat Model.
Richter B, Sanger C, Mussbach F, Scheuerlein H, Settmacher U, Dahmen U
Front Surg. 2022; 9:799669.
PMID: 35548189
PMC: 9081651.
DOI: 10.3389/fsurg.2022.799669.
Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma.
Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N, Vella I
Cancers (Basel). 2021; 13(15).
PMID: 34359560
PMC: 8345178.
DOI: 10.3390/cancers13153657.